Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors

Tecan is pleased to announce the launch of the Resolvex A200 Omics and Resolvex A200 24, the next generation of Resolvex A200 positive pressure processors. The Resolvex A200 is an industryproven, standalone system for automated positive pressure sample preparation, and the latest additions to the portfolio build on this success. These instruments boast unique capabilities to address unmet workflow needs and improve the flexibility and efficiency of the sample preparation process.

The Resolvex A200 Omics incorporates a HEPA filter and fully enclosed environment to reduce airborne particulates – like dust and keratin – minimizing the possibility of sample contamination in highly sensitive mass spectrometry workflows. The Resolvex A200 24 is compatible with larger format sample prep consumables – including 3 and 6 ml columns, as well as 24-well plates – to accommodate larger volume samples.

The system is also available with a number of cleverly designed accessories and adapters that allow users to run more workflows, such as giga-sized nucleic acid purification (NAP) methods. These automated solutions open up new applications, offering time savings and improved throughput while still providing the great reproducibility and robustness associated with the Resolvex brand. 

We are excited to be launching the Resolvex A200 Omics and 24, additions to the Resolvex A200 family that give scientists the ability to perform various workflows – from proteomics and bioanalytical processes to NAP and food safety workflows – with even better accuracy and throughput.” 

Dr Klaus Lun, Executive Vice President and Head of the Life Sciences Division at Tecan

To learn more about Tecan’s Resolvex A200 Omics and Resolvex A200 24, visit www.tecan.com/resolvex-a200-next-generation-positive-pressure-processing.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tecan. (2023, April 14). Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20230227/Boost-workflow-efficiency-and-flexibility-with-the-next-generation-of-Resolvexc2ae-A200-positive-pressure-processors.aspx.

  • MLA

    Tecan. "Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20230227/Boost-workflow-efficiency-and-flexibility-with-the-next-generation-of-Resolvexc2ae-A200-positive-pressure-processors.aspx>.

  • Chicago

    Tecan. "Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors". News-Medical. https://www.news-medical.net/news/20230227/Boost-workflow-efficiency-and-flexibility-with-the-next-generation-of-Resolvexc2ae-A200-positive-pressure-processors.aspx. (accessed April 19, 2024).

  • Harvard

    Tecan. 2023. Boost workflow efficiency and flexibility with the next generation of Resolvex® A200 positive pressure processors. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20230227/Boost-workflow-efficiency-and-flexibility-with-the-next-generation-of-Resolvexc2ae-A200-positive-pressure-processors.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer